Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS
Clinical trial NCT04557085 · COMPLETED
Trial details
- NCT number
- NCT04557085
- Sponsor
- SK Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2024-02-16
- Enrollment
- 519
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.